Cargando…
T4 + T3 combination therapy: any progress?
Guidelines on T4 + T3 combination therapy were published in 2012. This review investigates whether the issue is better understood 7 years later. Dissatisfaction with the outcome of T4 monotherapy remains high. Persistent symptoms consist mostly of fatigue, weight gain, problems with memory and think...
Autor principal: | Wiersinga, Wilmar M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794355/ https://www.ncbi.nlm.nih.gov/pubmed/31617166 http://dx.doi.org/10.1007/s12020-019-02052-2 |
Ejemplares similares
-
T4+T3 Combination Therapy: An Unsolved Problem of Increasing Magnitude and Complexity
por: Wiersinga, Wilmar M.
Publicado: (2021) -
Graves' Disease: Can It Be Cured?
por: Wiersinga, Wilmar M.
Publicado: (2019) -
Graves′ orbitopathy: Management of difficult cases
por: Wiersinga, Wilmar M.
Publicado: (2012) -
Clinical Relevance of Environmental Factors in the Pathogenesis of Autoimmune Thyroid Disease
por: Wiersinga, Wilmar M.
Publicado: (2016) -
The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches
por: Wiersinga, Wilmar M.
Publicado: (2008)